Optimising Surgical Outcomes: A Comprehensive

In the intricate world of surgery, particularly in procedures involving anastomoses (the connection of two tubular structures like blood vessels or intestines), success hinges on one critical factor: blood flow. A well-perfused anastomosis heals efficiently, while a poorly perfused one can lead to devastating complications like leaks, strictures, and tissue death.

For decades, surgeons relied on visual and tactile cues—color, pulsation, and bleeding from cut edges—to assess perfusion. While valuable, these methods are subjective and lack quantitative precision. Today, a technological revolution is providing real-time, objective data to guide surgical decision-making: Fluorescence-Based Perfusion Assessment with Indocyanine Green (ICG-FA).

This article delves into the science, procedure, and profound clinical impact of ICG-FA in modern surgical practice.

What is ICG-FA and How Does It Work?

Indocyanine Green Fluorescence Angiography (ICG-FA) is an advanced imaging technique that allows surgeons to visualize blood flow in real-time during a procedure. It functions on the principle of near-infrared (NIR) fluorescence.

The process involves two key components:

  1. The Fluorescent Agent: Indocyanine Green (ICG): ICG is a sterile, water-soluble, and non-toxic fluorescent dye. It binds tightly to plasma proteins upon intravenous injection and remains within the intravascular space, making it an ideal tracer for blood flow.
  2. The Imaging System: A specialized camera system, often integrated into the surgical laparoscope or used as a hand-held device, emits near-infrared light (around 806 nm). This light causes the ICG in the bloodstream to fluoresce, emitting light at a different wavelength (around 830 nm). The system captures this emitted light and projects a real-time, high-contrast video of the vascular network onto the monitor, with perfused areas glowing bright green.

The entire process from injection to visualization takes mere seconds, providing immediate feedback without significantly disrupting the surgical workflow.

The Critical Role of ICG-FA in Anastomotic Planning and Assessment

The primary application of ICG-FA is to ensure the viability of tissue before, during, and after creating an anastomosis. Its impact is most significant in the following surgical specialties:

  • Colorectal Surgery: Assessing perfusion before creating a colonic or rectal anastomosis to prevent anastomotic leak, a complication with a historical incidence of 1-19% and significant associated mortality.
  • Gastric and Esophageal Surgery: Evaluating gastric conduit perfusion during esophagectomy to reduce the risk of conduit necrosis and anastomotic leak.
  • Hepatobiliary and Pancreatic Surgery: Assessing blood flow to the liver and bile ducts.
  • Plastic and Reconstructive Surgery: Evaluating blood flow in free flaps and pedicled flaps to ensure graft survival.
  • Cardiovascular Surgery: Assessing graft patency and coronary perfusion.

The ICG-FA Procedure: A Step-by-Step Guide

The integration of ICG-FA into a surgical procedure is streamlined and efficient.

  1. Preoperative Planning:
    • Patient Screening: Confirming no known iodine or ICG allergy. While rare, ICG contains sodium iodide and is contraindicated in patients with severe iodine hypersensitivity.
    • Informed Consent: The off-label use of ICG for perfusion assessment (it is FDA-approved for other indications) is often discussed with the patient as part of the surgical plan.
    • System Setup: The NIR camera system is calibrated and positioned for an optimal view of the target tissue.
  2. Intraoperative Execution:
    • Surgical Dissection: The surgeon proceeds with the standard approach, mobilizing the organ (e.g., the colon) and preparing the segments for anastomosis.
    • Baseline Assessment: The surgical site is inspected under white light, and the NIR camera is activated to establish a non-fluorescent baseline.
    • ICG Administration: A standard, low dose of ICG (typically 5-10 mg, or 0.1-0.2 mg/kg) is injected intravenously as a bolus.
    • Real-Time Imaging: Within 15-45 seconds, the fluorescent signal appears, mapping the arterial inflow, capillary perfusion, and venous drainage. The surgeon observes the dynamic flow of the “green wave” through the tissue.
    • Assessment and Decision-Making: The surgeon assesses the intensity and uniformity of fluorescence at the planned anastomotic site. A well-defined, bright, and homogenous glow indicates good perfusion. A poorly defined, patchy, or absent signal indicates hypoperfusion (ischemia).
  3. Post-Imaging Action & Treatment Plan:
    The ICG-FA findings directly dictate the subsequent surgical steps, forming a critical feedback loop.
    • If Perfusion is Adequate: The surgeon proceeds with confidence to create the anastomosis at the planned location.
    • If Perfusion is Inadequate: The surgeon must now make a data-driven decision. The treatment plan may involve:
      • Further Resection: The ischemic segment is resected until well-perfused, fluorescent tissue is reached. Studies have shown that ICG-FA can lead to a change in the anastomotic site in up to 10-15% of colorectal cases.
      • Re-evaluation: After resection, a second, smaller dose of ICG can be administered to confirm the new resection margin has adequate perfusion.
      • Altered Surgical Strategy: In extreme cases, the findings may necessitate a change in the entire operative plan, such as creating a diverting stoma to protect a tenuous anastomosis or opting for a different reconstructive technique.

Quantifiable Benefits and Clinical Impact

The adoption of ICG-FA is supported by a growing body of evidence demonstrating tangible improvements in patient outcomes.

  • Reduced Anastomotic Leak Rates: Multiple studies and meta-analyses have reported a relative risk reduction of 30-50% in anastomotic leak rates in colorectal surgery when ICG-FA is utilized.
  • Decreased Reoperation Rates: By preventing leaks, ICG-FA directly reduces the need for emergent, high-risk reoperations.
  • Shorter Hospital Stays: Fewer complications translate to faster recovery and reduced length of stay, leading to lower healthcare costs and improved patient satisfaction.
  • Enhanced Surgeon Confidence: The objective data provided by ICG-FA reduces intraoperative uncertainty, allowing for more precise and confident surgical execution.

Limitations and Future Directions

While powerful, ICG-FA is not without limitations. It provides a qualitative or semi-quantitative assessment, and interpretation can have a learning curve. The fluorescence signal can be influenced by factors like tissue depth, ambient light, and patient body habitus. Future advancements are focused on developing quantitative ICG-FA (q-ICG) software that can provide numerical values for perfusion parameters like ingress, slope, and egress, further standardizing assessment.

Indocyanine Green Fluorescence Angiography (ICG-FA) has emerged as a transformative tool in the surgeon’s arsenal. By moving beyond subjective assessment to provide real-time, objective visualisation of tissue perfusion, it empowers surgeons to make critical, data-driven decisions that directly prevent complications. As the technology continues to evolve and become more quantitative, its role in standardising care and optimising patient outcomes across a broad spectrum of surgical disciplines will only become more profound. In the pursuit of surgical perfection, ICG-FA is illuminating the path forward.